Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C

被引:41
作者
Wang, Tao [1 ]
Zhang, Wenyan [1 ,2 ]
Tian, Chunjuan [2 ]
Liu, Bindong [1 ]
Yu, Yunkai [1 ]
Ding, Lingmei [3 ,4 ,5 ]
Spearman, Paul [3 ,4 ,5 ]
Yu, Xiao-Fang [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Microbiol & Immunol, Baltimore, MD 21205 USA
[2] Jilin Univ, Jilin, Peoples R China
[3] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Microbiol, Atlanta, GA 30322 USA
[5] Emory Univ, Dept Immunol, Atlanta, GA 30322 USA
关键词
APOBEC3G; Vif HIV-1; cytidine deaminase; APOBEC3C;
D O I
10.1016/j.virol.2008.04.012
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human APOBEC3G and other APOBEC3 cytidine deaminases inhibit a variety of retroviruses, including Vif-deficient HIV-1. These host proteins are packaged into viral particles and inhibit the replication of virus in new target cells. A3G and A3F are known to be efficiently packaged into HIV-1 virions by binding to 7SL RNA through the Gag NC domain; however, the packaging mechanisms of other APOBEC3 proteins are poorly defined. We have now demonstrated that APOBEC3C (A3C) can be efficiently packaged into HIV-1 virions that are deficient for viral genomic RNA. Inhibition of the encapsidation of 7SL RNA into HIV-1 virions blocked the packaging of A3G, but not A3C. While the NC domain is required for efficient packaging of A3G, deletion of this domain had little effect on A3C packaging into HIV-1 Gag particles. A3C interacted with HIV-1 Gag which was MA domain-dependent and RNA-dependent. Deletion of the MA domain of HIV-1 Gag inhibited A3C but not A3G packaging into HIV-1 Gag particles. Thus, A3G and A3C have evolved to use distinct mechanisms for targeting retroviruses. (c) 2008 Published by Elsevier Inc.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 88 条
[1]   APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein [J].
Alce, TM ;
Popik, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) :34083-34086
[2]  
Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177
[3]   Intrinsic immunity: a front-line defense against viral attack [J].
Bieniasz, PD .
NATURE IMMUNOLOGY, 2004, 5 (11) :1109-1115
[4]   Antiviral potency of APOBEC proteins does not correlate with cytidine deamination [J].
Bishop, Kate N. ;
Holmes, Rebecca K. ;
Malim, Michael H. .
JOURNAL OF VIROLOGY, 2006, 80 (17) :8450-8458
[5]   Cellular inhibitors of long interspersed element 1 and Alu retrotransposition [J].
Bogerd, Hal P. ;
Wiegand, Heather L. ;
Hulme, Amy E. ;
Garcia-Perez, Jose L. ;
O'Shea, K. Sue ;
Moran, John V. ;
Cullen, Bryan R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (23) :8780-8785
[6]   Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication [J].
Bonvin, Marianne ;
Achermann, Francois ;
Greeve, Isabell ;
Stroka, Deborah ;
Keogh, Adrian ;
Inderbitzin, Daniel ;
Candinas, Daniel ;
Sommer, Peter ;
Wain-Hobson, Simon ;
Vartanian, Jean-Pierre ;
Greeve, Jobst .
HEPATOLOGY, 2006, 43 (06) :1364-1374
[7]   HIV-1 MATRIX PROTEIN P17 RESIDES IN CELL-NUCLEI IN ASSOCIATION WITH GENOMIC RNA [J].
BUKRINSKAYA, AG ;
VORKUNOVA, GK ;
TENTSOV, YY .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (10) :1795-1801
[8]   APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC linker [J].
Burnett, Atuhani ;
Spearman, Paul .
JOURNAL OF VIROLOGY, 2007, 81 (10) :5000-5013
[9]   Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein [J].
Burniston, MT ;
Cimarelli, A ;
Colgan, J ;
Curtis, SP ;
Luban, J .
JOURNAL OF VIROLOGY, 1999, 73 (10) :8527-8540
[10]   The interaction between HIV-1 Gag and APOBEC3G [J].
Cen, S ;
Guo, F ;
Niu, MJ ;
Saadatmand, J ;
Deflassieux, J ;
Kleiman, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :33177-33184